AKT-5573

A randomised controlled trial was conducted to test a new treatment for preventing recurrence of stroke. The trial involved 1000 patients who were randomly assigned to receive the new treatment and another 1000 patients who received standard therapy. During the trial, 66 patients who received the new treatment suffered a recurrent stroke, while 110 patients in the control group experienced the same outcome. What is the relative risk reduction in the treatment group?